- Home
- GNFT vs DENN Comparison
GNFT vs DENN Comparison
Compare GNFT & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- DENN
- Stock Information
- Founded
- GNFT 1999
- DENN 1953
- Country
- GNFT France
- DENN United States
- Employees
- GNFT N/A
- DENN N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- DENN Restaurants
- Sector
- GNFT Health Care
- DENN Consumer Discretionary
- Exchange
- GNFT Nasdaq
- DENN Nasdaq
- Market Cap
- GNFT 186.3M
- DENN 203.4M
- IPO Year
- GNFT 2019
- DENN 1989
- Fundamental
- Price
- GNFT $4.11
- DENN $4.03
- Analyst Decision
- GNFT Strong Buy
- DENN Strong Buy
- Analyst Count
- GNFT 1
- DENN 7
- Target Price
- GNFT $13.00
- DENN $6.96
- AVG Volume (30 Days)
- GNFT 3.9K
- DENN 660.3K
- Earning Date
- GNFT 09-18-2025
- DENN 08-04-2025
- Dividend Yield
- GNFT N/A
- DENN N/A
- EPS Growth
- GNFT N/A
- DENN N/A
- EPS
- GNFT 0.03
- DENN 0.30
- Revenue
- GNFT $73,187,701.00
- DENN $455,727,000.00
- Revenue This Year
- GNFT $5.15
- DENN $7.47
- Revenue Next Year
- GNFT N/A
- DENN $1.97
- P/E Ratio
- GNFT $132.29
- DENN $13.41
- Revenue Growth
- GNFT 105.01
- DENN 0.06
- 52 Week Low
- GNFT $2.55
- DENN $2.85
- 52 Week High
- GNFT $6.42
- DENN $7.73
- Technical
- Relative Strength Index (RSI)
- GNFT 58.92
- DENN 53.87
- Support Level
- GNFT $3.71
- DENN $3.36
- Resistance Level
- GNFT $4.12
- DENN $4.18
- Average True Range (ATR)
- GNFT 0.15
- DENN 0.21
- MACD
- GNFT 0.02
- DENN 0.03
- Stochastic Oscillator
- GNFT 82.95
- DENN 70.53
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.